Compare BCTX & NUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BCTX | NUR |
|---|---|---|
| Founded | 2014 | N/A |
| Country | Canada | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.1M | 25.2M |
| IPO Year | 2025 | 2016 |
| Metric | BCTX | NUR |
|---|---|---|
| Price | $4.10 | $1.01 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $40.00 | N/A |
| AVG Volume (30 Days) | 243.4K | ★ 4.0M |
| Earning Date | 06-15-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $380.95 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.60 | $0.95 |
| 52 Week High | $14.68 | $7.72 |
| Indicator | BCTX | NUR |
|---|---|---|
| Relative Strength Index (RSI) | 63.59 | 32.17 |
| Support Level | $4.10 | $0.95 |
| Resistance Level | $4.38 | $7.72 |
| Average True Range (ATR) | 0.20 | 0.63 |
| MACD | 0.05 | -0.09 |
| Stochastic Oscillator | 78.49 | 1.13 |
BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.